ALOX5 and familial pancreatic carcinoma: A number LO inhibitors including the specific 5-LO inhibitor REV5901 altered pancreatic cancer cell proliferation through an induction of apoptosis with decreased Bcl2 and Mcl2 and increased Bax expression being reported [78].